Combination Immunotherapy With Herceptin and the HER2 Vaccine E75 in Low and Intermediate HER2- expressing Breast Cancer Patients to Prevent Recurrence, NCT01570036. The gene discussed is ERBB2; the disease is breast carcinoma.